UK Pruritus Therapeutics Market Size & Outlook, 2024-2030

The pruritus therapeutics market in UK is expected to reach a projected revenue of US$ 440.3 million by 2030. A compound annual growth rate of 4.9% is expected of UK pruritus therapeutics market from 2025 to 2030.
Revenue, 2024 (US$M)
$330.2
Forecast, 2030 (US$M)
$440.3
CAGR, 2025 - 2030
4.9%
Report Coverage
UK

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK pruritus therapeutics market, 2018-2030 (US$M)

UK pruritus therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UK pruritus therapeutics market highlights

  • The UK pruritus therapeutics market generated a revenue of USD 343.0 million in 2024 and is expected to reach USD 478.2 million by 2030.
  • The UK market is expected to grow at a CAGR of 5.7% from 2025 to 2030.
  • In terms of segment, atopic dermatitis was the largest revenue generating disease in 2024.
  • Allergic contact dermatitis is the most lucrative disease segment registering the fastest growth during the forecast period.

Pruritus therapeutics market data book summary

Market revenue in 2024USD 343.0 million
Market revenue in 2030USD 478.2 million
Growth rate5.7% (CAGR from 2025 to 2030)
Largest segmentAtopic dermatitis
Fastest growing segmentAllergic contact dermatitis
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAtopic dermatitis, Allergic contact dermatitis, Urticaria, Other Diseases
Key market players worldwideAbbVie Inc, Teva Pharmaceutical Industries Ltd, Amgen Inc, Astellas Pharma Inc, Bristol-Myers Squibb Co, Cara Therapeutics Inc, GlaxoSmithKline, Viatris Inc, Novartis AG ADR, Pfizer Inc, Sanofi SA

Other key industry trends

  • In terms of revenue, UK accounted for 3.8% of the global pruritus therapeutics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany pruritus therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 478.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pruritus Therapeutics Market Companies

Name Profile # Employees HQ Website

UK pruritus therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pruritus therapeutics market will help companies and investors design strategic landscapes.


Atopic dermatitis was the largest segment with a revenue share of 42.07% in 2024. Horizon Databook has segmented the UK pruritus therapeutics market based on atopic dermatitis, allergic contact dermatitis, urticaria, other diseases covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UK pruritus therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK pruritus therapeutics market databook

  • Our clientele includes a mix of pruritus therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK pruritus therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into UK pruritus therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK pruritus therapeutics market size, by disease, 2018-2030 (US$M)

UK Pruritus Therapeutics Market Outlook Share, 2024 & 2030 (US$M)

UK pruritus therapeutics market size, by disease, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online